Book Details
Orange Code:59926
Paperback:305 pages
Publications:
Categories:
Sections:
1. Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs2. Discovery of Novel Targets3. Novel Anti-angiogenic Therapies in Ovarian Cancer4. Targeting the AKT Pathway in Ovarian Cancer5. Inhibition of the Src Oncogene: Therapeutic PotentialINTbreak; in Ovarian Carcinoma6. Tumour-Specific Synthetic Lethality: Targeting BRCA Dysfunction in Ovarian Cancer7. Targeting Inflammatory Pathways in Epithelial Ovarian Cancer8. Epithelial-to-Mesenchymal Transition and Cellular Membrane Receptors in Ovarian Cancer: Moving Forward in the Era of Molecularly Targeted Therapy9. Epigenetic Therapies10. Ovarian Cancer Immunology and Immunotherapy11. Ovarian Cancer Progenitor/Stem Cells: Therapeutic Potential12. Potential for -Folate Receptor-Targeted TreatmentINTbreak; for Ovarian Cancer13. New Insights into Tubulin Binders
Description:
|
This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers.
|
